Rennova Health, Inc. (RNVA): Llc Alcimede , CEO of Rennova Health, Inc. purchased 10,900 shares on Jun 8, 2016. The Insider buying transaction was reported by the company on Jul 15, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.58 per share for a total value of $4,192.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 15, 2016, Jason Adams (CFO) purchased 1,160 shares at $0.28 per share price.
Rennova Health Inc. formerly CollabRx Inc. is a healthcare solutions company which offers diagnostics and supportive software solutions to healthcare providers. The Company develops and operates businesses systems and services that support treatment outcomes patient care and revenue streams. The Company’s solutions include diagnostic solutions revenue cycle management healthcare software solutions and financial services. Its Medytox Diagnostics owns and operates approximately five labs. The Company also offers solutions which include diagnostic laboratory testing and analytics for precision medicine electronic health records (EHRs) and other software services and medical billing and financial services for revenue cycle management. Its financial services solutions offer loans to healthcare providers. The Company operates under Medytox Diagnostics Medical Billing Choices Medytox Advantage Medical Mime ClinLab and Platinum Financial Solutions brands.